Loading
Life sciences · Journal article
Biomolecules · October 29, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Natural compounds and their derivatives have traditionally made a significant contribution to pharmacotherapy, especially in cancer, cardiovascular, infectious, and COVID-19-related diseases. They offer significant advantages over traditional small molecules, including high structural diversity, rigid scaffold architecture and rich stereochemistry, and the ability to modulate multiple biological pathways and targets. Moreover, their use in traditional medicine provides valuable information for drug discovery; however, traditional uses alone do not establish their safety and efficacy. The development of natural products into clinically useful drugs remains challenging due to technical barriers in screening, isolation, characterization, and optimization, poor bioavailability, and patent and regulatory challenges. The current development of analytical technology and nanocarrier-based delivery systems, including polymeric nanoparticles, solid lipid nanoparticles, micelles, and liposomes, is addressing such challenges and limitations by improving drug stability, solubility, bioavailability, and targeted delivery. This has sparked interest in natural products as potential drugs for treating diseases like cancer, cardiovascular diseases, and COVID-19-related diseases. Therefore, this review comprehensively discusses the mechanisms by which natural products exert their therapeutic effect and highlights recent advances in formulation and drug delivery strategies. It also summarizes current applications of formulation approaches and discusses their potential to improve the therapeutic efficacy and clinical translation of natural-based therapies. The review bridges mechanistic insights with innovative formulation strategies to provide a focused perspective on the potential of natural products for disease management.